364 related articles for article (PubMed ID: 31771195)
1. The Biological Bases of Group 2 Pulmonary Hypertension.
Fernández AI; Yotti R; González-Mansilla A; Mombiela T; Gutiérrez-Ibanes E; Pérez Del Villar C; Navas-Tejedor P; Chazo C; Martínez-Legazpi P; Fernández-Avilés F; Bermejo J
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31771195
[TBL] [Abstract][Full Text] [Related]
2. Clinical phenotypes and outcomes of pulmonary hypertension due to left heart disease: Role of the pre-capillary component.
Caravita S; Faini A; Carolino D'Araujo S; Dewachter C; Chomette L; Bondue A; Naeije R; Parati G; Vachiéry JL
PLoS One; 2018; 13(6):e0199164. PubMed ID: 29920539
[TBL] [Abstract][Full Text] [Related]
3. Left ventricular heart failure and pulmonary hypertension.
Rosenkranz S; Gibbs JS; Wachter R; De Marco T; Vonk-Noordegraaf A; Vachiéry JL
Eur Heart J; 2016 Mar; 37(12):942-54. PubMed ID: 26508169
[TBL] [Abstract][Full Text] [Related]
4. [Pulmonary hypertension – a common condition in left heart disease].
Lundgren J; Rådegran G
Lakartidningen; 2017 Dec; 114():. PubMed ID: 29292958
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary hypertension associated with left heart disease: characteristics, emerging concepts, and treatment strategies.
Haddad F; Kudelko K; Mercier O; Vrtovec B; Zamanian RT; de Jesus Perez V
Prog Cardiovasc Dis; 2011; 54(2):154-67. PubMed ID: 21875514
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary hypertension associated with left heart disease.
Wissmüller M; Dohr J; Adler J; Ochs L; Tichelbäcker T; Hohmann C; Baldus S; Rosenkranz S
Herz; 2023 Aug; 48(4):266-273. PubMed ID: 37289211
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary Hypertension Due to Left Heart Disease: Diagnosis, Pathophysiology, and Therapy.
Al-Omary MS; Sugito S; Boyle AJ; Sverdlov AL; Collins NJ
Hypertension; 2020 Jun; 75(6):1397-1408. PubMed ID: 32336230
[TBL] [Abstract][Full Text] [Related]
8. Understanding the Pathobiology of Pulmonary Hypertension Due to Left Heart Disease.
Huston JH; Shah SJ
Circ Res; 2022 Apr; 130(9):1382-1403. PubMed ID: 35482841
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary hypertension due to left heart disease: The prognostic implications of diastolic pulmonary vascular pressure gradient.
Ibe T; Wada H; Sakakura K; Ikeda N; Yamada Y; Sugawara Y; Mitsuhashi T; Ako J; Fujita H; Momomura S
J Cardiol; 2016 Jun; 67(6):555-9. PubMed ID: 26299611
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary hypertension due to left heart diseases.
Vachiéry JL; Adir Y; Barberà JA; Champion H; Coghlan JG; Cottin V; De Marco T; Galiè N; Ghio S; Gibbs JS; Martinez F; Semigran M; Simonneau G; Wells A; Seeger W
J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D100-8. PubMed ID: 24355634
[TBL] [Abstract][Full Text] [Related]
11. Left Heart Disease and Pulmonary Hypertension: Are We Seeing the Full Picture?
Chung K; Strange G; Codde J; Celermajer D; Scalia GM; Playford D
Heart Lung Circ; 2018 Mar; 27(3):301-309. PubMed ID: 29102471
[TBL] [Abstract][Full Text] [Related]
12. Significance of Pulmonary Vascular Resistance and Diastolic Pressure Gradient on the New Definition of Combined Post-Capillary Pulmonary Hypertension.
Sugimoto K; Yoshihisa A; Nakazato K; Yokokawa T; Misaka T; Oikawa M; Kobayashi A; Yamaki T; Kunii H; Ishida T; Takeishi Y
Int Heart J; 2020; 61(2):301-307. PubMed ID: 32224602
[TBL] [Abstract][Full Text] [Related]
13. A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats.
Sang P; Kucherenko MM; Yao J; Li Q; Simmons S; Kuebler WM; Knosalla C
J Vis Exp; 2022 Mar; (181):. PubMed ID: 35311828
[TBL] [Abstract][Full Text] [Related]
14. Lung Capillary Stress Failure and Arteriolar Remodelling in Pulmonary Hypertension Associated with Left Heart Disease (Group 2 PH).
Dayeh NR; Ledoux J; Dupuis J
Prog Cardiovasc Dis; 2016; 59(1):11-21. PubMed ID: 27195752
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary Hypertension in Heart Failure. Epidemiology, Right Ventricular Function, and Survival.
Gerges M; Gerges C; Pistritto AM; Lang MB; Trip P; Jakowitsch J; Binder T; Lang IM
Am J Respir Crit Care Med; 2015 Nov; 192(10):1234-46. PubMed ID: 26181215
[TBL] [Abstract][Full Text] [Related]
16. Diastolic Pressure Difference to Classify Pulmonary Hypertension in the Assessment of Heart Transplant Candidates.
Wright SP; Moayedi Y; Foroutan F; Agarwal S; Paradero G; Alba AC; Baumwol J; Mak S
Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28912262
[TBL] [Abstract][Full Text] [Related]
17. Mechanical stretching of pulmonary vein stimulates matrix metalloproteinase-9 and transforming growth factor-β1 through stretch-activated channel/MAPK pathways in pulmonary hypertension due to left heart disease model rats.
Zhang H; Huang W; Liu H; Zheng Y; Liao L
PLoS One; 2020; 15(9):e0235824. PubMed ID: 32881898
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary hypertension due to left heart disease: analysis of survival according to the haemodynamic classification of the 2015 ESC/ERS guidelines and insights for future changes.
Palazzini M; Dardi F; Manes A; Bacchi Reggiani ML; Gotti E; Rinaldi A; Albini A; Monti E; Galiè N
Eur J Heart Fail; 2018 Feb; 20(2):248-255. PubMed ID: 28464427
[TBL] [Abstract][Full Text] [Related]
19. [Pulmonary hypertension associated with left heart disease (group 2)].
Wissmüller M; Tichelbäcker T; Finke K; Dohr J; Adler J; Ochs L; Hohmann C; Baldus S; Rosenkranz S
Dtsch Med Wochenschr; 2023 Nov; 148(23):1498-1506. PubMed ID: 37949078
[TBL] [Abstract][Full Text] [Related]
20. The pathophysiology of pulmonary hypertension in left heart disease.
Breitling S; Ravindran K; Goldenberg NM; Kuebler WM
Am J Physiol Lung Cell Mol Physiol; 2015 Nov; 309(9):L924-41. PubMed ID: 26502478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]